Skip to content

Clinical trials

Phase 1 Carcinoma, Non-Small-Cell Lung trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1 Country / region: Japan Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20083
20094
20106
20112
20122
20144
20154
20164
20175
20185
20194
20205
202112
202210
20236
202414
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Active, not recruiting24
Terminated21
Recruiting20
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals13
Eli Lilly and Company11
AbbVie10
AstraZeneca7
Pfizer7
Boehringer Ingelheim5
Amgen3
Daiichi Sankyo3
Kyowa Kirin Co., Ltd.3
Blueprint Medicines Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung100
Neoplasms24
Colorectal Neoplasms19
Squamous Cell Carcinoma of Head and Neck19
Neoplasm Metastasis17
Triple Negative Breast Neoplasms15
Melanoma14
Lung Neoplasms13
Stomach Neoplasms13
Carcinoma, Renal Cell11

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.